Basic infomation |
source |
Mouse |
Clonality |
Polyclonal |
|
Isotype |
IgG |
|
Reactivity |
H M R |
|
MW (kDa) |
60kDa |
|
Purification |
Antigen affinity purfication |
|
UniProt ID |
O13485 |
|
NCBI Gene |
4089 |
|
|
|
|
Applications |
Tested Applications |
WB, |
Cited Applications |
WB, IHC, IF |
|
Product Usage Information |
Western Blotting |
1:1000-1:2000 |
Immunohistochemistry |
1:200-1:400 |
|
Immunofluorescence |
1:200-1:400 |
|
|
|
|
Storage |
PBS with 50% glycerol and less than 0.02% sodium azide |
|
Store at –20°C, stable for one year after shipment |
||
Do not aliquot the antibody |
||
|
||
Background |
This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. |
|
|
|
|
Abbreviation |
H: human M: mouse R: rat Rb: rabbit Hm: hamster Mk: monkey Vir: virus C: chicken Z: zebrafish Dg: dog Pg: pig Hr: horse |